Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
about
Genetic susceptibility to advanced retinopathy of prematurity (ROP)Supplemental oxygen for the treatment of prethreshold retinopathy of prematurityThe alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesisGlucose, VEGF-A, and diabetic complicationsSelective inhibition of retinal angiogenesis by targeting PI3 kinaseLack of collagen XVIII/endostatin results in eye abnormalitiesERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expressionN-CAM exhibits a regulatory function in pathological angiogenesis in oxygen induced retinopathyOxygen Use in Neonatal Care: A Two-edged SwordThe mouse retina as an angiogenesis model.Diode laser treatment of posterior retinopathy of prematurity.Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity.Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.Review of the ocular angiogenesis animal models.Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.Role of pegaptanib sodium in the treatment of neovascular age-related macular degenerationMicrovascular patterning is controlled by fine-tuning the Akt signal.Retinopathy of prematurity: the need for prevention.High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysisVitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema.Retinopathy of prematurity: current concepts in molecular pathogenesis.Genome-wide census and expression profiling of chicken neuropeptide and prohormone convertase genes.NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.Bim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia.The alternative complement pathway regulates pathological angiogenesis in the retinaLaser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gainIntravitreal bevacizumab in retinopathy of prematurity: an interventional case series.An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration.[Pharmacological treatment for retinopathy of prematurity].Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity.Pregnancy disorders appear to modify the risk for retinopathy of prematurity associated with neonatal hyperoxemia and bacteremia.Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis.Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity.
P2860
Q21093659-3B34197E-77FF-4DDE-A397-2ACBBA90FCD9Q24248656-E03D20BF-5752-4E6C-8357-ABE93A50AFE8Q28344804-5A9F863E-E4AB-473B-9F05-47C561FE87A2Q28362039-FA211E8D-E617-4323-ADF7-42C1448B1A9EQ28471888-015B1108-434E-43E5-9828-3D78EAA7D11AQ28511317-F4B986FD-A9F3-431A-94D8-D44F0FD7338BQ28591302-D0753D82-BCAF-4787-AEFD-565713860F29Q28743741-4D7A0E31-E527-40F5-B061-E1FC2D291390Q30365148-BBC9F8E2-5AC5-4F33-8FB2-48E12222585EQ30495106-855E1171-682D-488E-B8A9-2949A003E757Q30968551-D05B6BB3-09DA-426E-A766-34859171AD4EQ30992212-E6042208-B600-43AB-A35B-C8E29A0A1C29Q33210617-D25AF8FF-F6B9-4183-A866-C24631F94BC0Q33261163-D8E5A276-0F9D-4012-8558-182EBECC20E1Q33293815-6B66F703-54C1-4880-911C-21ACA3921955Q33342892-19C071BC-D51F-4C42-801D-F849C64182FDQ33431314-B7766D10-DC3F-4453-A1A3-A5213D66D199Q33450271-CFB5E347-B5F5-471B-B363-243B4477E139Q33492369-86822C00-17F9-4E08-91F8-EDB16BE8B281Q33551411-12DC7DD1-53F8-4A9F-B4C2-34D72BC6179BQ33585466-D1B0DF61-D7AB-4DD7-B90A-25CA2C122294Q33593430-7FC60104-60B0-423B-9556-D2C9EB76B579Q33593437-A0DF21AC-5566-4E48-87D4-FE770E36C63CQ33606227-1AB03EF6-9F5D-4B9D-94B1-D2D58B0CB982Q33621181-8977E9EA-13D4-4A6F-8310-FCF1EFDED6C8Q33632781-0B940CD6-1421-469F-8CB9-4A1B85A05654Q33737167-F44FA3BF-A6C2-4A56-89FC-E3908977E775Q33775122-5D78689F-90A9-43A7-AD78-01312D73DFD5Q33782646-B5E76DAA-C60B-4973-A3C7-7947444E7863Q33787955-7491DB92-0D2E-4311-BBAD-727025E6FDF2Q33820526-2210AF17-1E62-45D3-B156-DC6DBEB56C15Q33873875-6EE943FE-316D-4240-A99D-B2F12813F3E7Q33943213-3A66D109-E466-461F-A470-EE292AD7619BQ33997311-2645BB36-F68C-4DA3-9A03-35BBFDD37F33Q34087039-DD0256FF-FB97-4C6F-BAF0-EA18CC54A88DQ34130329-C5CDC6CB-60D6-44BE-9FF2-4DFF6AEFA86BQ34205668-2FD6D608-0E06-4424-BD1E-8C0907E58280Q34445200-00B5DB77-DF65-4568-AD6E-04346BD3C85EQ34544365-79062382-C07A-4EF3-95CC-7DC279AB9C96Q34553207-5C788EF7-5AF4-401B-AA66-973E215B1F8D
P2860
Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Regulation of vascular endothe ...... of retinopathy of prematurity.
@en
Regulation of vascular endothe ...... of retinopathy of prematurity.
@nl
type
label
Regulation of vascular endothe ...... of retinopathy of prematurity.
@en
Regulation of vascular endothe ...... of retinopathy of prematurity.
@nl
prefLabel
Regulation of vascular endothe ...... of retinopathy of prematurity.
@en
Regulation of vascular endothe ...... of retinopathy of prematurity.
@nl
P1433
P1476
Regulation of vascular endothe ...... of retinopathy of prematurity.
@en
P2093
P304
P356
10.1001/ARCHOPHT.1996.01100140419009
P407
P577
1996-10-01T00:00:00Z